PMGC Holdings subsidiary NorthStrive amends YuvaBio deal for three-phase expansion
PMGC Holdings, via subsidiary NorthStrive Biosciences, entered a First Amendment with Yuva Biosciences on Aug 27, 2026 to launch a three-phase Expansion Program advancing up to four AI-discovered compounds toward lead nomination.